More Information

Colloquium

Each semester, a colloquium series is organized by the Institute for Biotechnology to expose the students in the program to prominent speakers from the academic and industrial settings. The colloquium series is open to all and is typically attended by members of the Institute for Biotechnology as well as the students and faculty from St. John’s College and the College of Pharmacy and Health Sciences. The colloquium series serves as an excellent opportunity for networking while learning about various facets of research in Biotechnology and its interdisciplinary nature.

Spring 2016

Dr. Eric E. Schadt - February 3, 2016
Director, Icahn Institute for Genomics and Multiscale Biology, Mount Sinai, NY
“An Information Approach to Reinventing Medicine”

Dr. Gerard Honig - March 16, 2016
Founder & CEO, Symbiotic Health Inc., Roslyn Heights, NY
“Microbiome-based biologic therapeutics for enteric infections”

Dr. Prem K. Premsrirut - April 13, 2016
President and CEO, Mirimus, Inc., Woodbury, NY
“RNAi and CRISPR/Cas9 applications for drug discovery in vivo”

Dr. Shaomeng Wang - April 20, 2016
Director/Professor of Medicine, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI
“Building a successful drug discovery program in academia”

Fall 2015

Dr. Brian R. Gibney - September 23, 2015
Professor, Brooklyn College, Brooklyn, NY
“Iron-Sulfur Protein Design”

Dr. Srinivas Pentyala - November 3, 2015
Director and Associate Professor of Anesthesiology, Stony Brook Medical Center,
Stony Brook, NY
“Found In Translation – Science That Makes Sense”

Dr. Daniel Grande - November 17, 2015
Director, Orthopedic Research Laboratory, The Feinstein Institute for Medical Research, Manhasset, NY
“Regenerative Medicine Strategies for the Musculoskeletal System”

Spring 2015

Dr. Marc Symons - February 11, 2015
Co-Director, Brain Tumor Biotech Center, Feinstein Institute Medical Research, Manhasset, NY
“Developing novel strategies for the treatment of brain tumors”

Dr. Ashley Thomas Martino - March 25, 2015
Assistant Professor, Pharmaceutical Sciences, St. John’s University, Jamaica, NY
“Improving the Efficiency of Viral Gene Therapy Drugs to Stably Deliver Genes to Treat
Genetic Diseases”

Dr. Anis A. Khan - April 15, 2015
Principal Clinical Pharmacokineticist,  MedImmune, Gaithersburg, MD
“Quantitative Aspects of Biologics Discovery and Development – An Industrial
Perspective”

Fall 2014

Dr. Vladimir Poltoratsky - October 14, 2014
Assistant Professor, St. John’s University, Jamaica, NY
“The role of the DNA repair proteins in maturation of B cells”

Dr. Asim K. Debnath - November 11, 2014
Head, Laboratory of Molecular Modeling & Drug Design, New York Blood Center, New York, NY
“Designing Entry Inhibitors targeted to the Phe43 cavity of HIV-1 gp120”

Dr. Ramaswamy Iyer - November 18, 2014
Director, Bristol Myer Squibb, Princeton, NJ
“Metabolism Studies on Pharmaceutical Drugs: From Small Molecules to Antibody Drug Conjugates (ADC)”

Spring 2014

Dr. Yong Yu - February 11, 2014
Dept. of Biological Sciences, St. John’s University, Jamaica, NY
“TRPP/PKD Receptor-ion Channel Complexes: Assembly, Function and their Role in Human Disease”

Dr. John Haley - March 25, 2014
Senior Director Network Pharmacology LLC, Sea Cliff, NY
“Emerging strategies for cancer drug discovery and development”

Fall 2013

Dr. Woon-Kai Low - October 9, 2013
Assistant Professor, St. John’s University, Jamaica, NY
“Development of the marine natural produce Pateamine A as a potential novel anti-cancer agent”

Dr. Jonathon Walls - November 6, 2013
Scientist, Regeneron Pharmaceuticals, Tarrytown, NY
“3D Imagining as a Tool for Mouse Phenotyping”

Dr. Giuseppe de Peppo - December 4, 2013
Principal Investigator, NYSCF, New York, NY
“Tissue Engineering and Regenerative Medicine”

Spring 2013

Dr. Dong-Hua Yang - February 19, 2013
Assistant Research Professor, Fox Chase Cancer Center
“AQUA: the future for biomarker research”

Eric A. Greenbaum, M.S. J.D. - March 19, 2013
Registered Patent Attorney & Biochemist, Greenbaum P.C.
“SciIP: Intellectual Property for Scientist”

Dr. Jose M. Galarza - April 30, 2013
CEO & President TechnoVax Inc.
“Evolution of Vaccines to Current Technologies and Beyond”

Fall 2012

Dr. Niven Narain - Wednesday, October 10, 2012
President & CTO - Berg Biosystems, Natick, MA
“Interrogative biology: A novel platform for the engagement of biointelligence and
drug discovery”

Dr. Renuka Pillutla - Wednesday, November 14, 2012
Associate Director – Bioanalytical  Sciences, Biologics Bristol-Myers Squibb, Princeton, NJ
“Immunogenicity Testing of Biotherapeutics”

Dr. Dana Ferraris - Wednesday, December 5, 2012
Principal Scientist – Brain Science Institute Johns Hopkins University, Baltimore, MD
“Poly (ADP-ribose) Polymerases (PARPs) as therapeutic targets”

Spring 2012

Dr. Prem Premsrirut -Wednesday, February 8, 2012
President and CEO,  Mirimus Inc., Cold Spring Harbor, NY
“RNAi mouse models for target discovery, validation and toxicology assessment'’

Dr. Phil Lukeman -Wednesday, March 14, 2012
Associate Professor of Organic Chemistry, Department of Chemistry, St. John’s University, NY
“Nanochemistry for Noobs: Nanodoodads built by Novices from Nucleic Acids”

Dr. Ray Huang -Wednesday, April 18, 2012
Founder and President , RayBiotech Inc., Norcross, GA
“Accelerated biomedical discovery using protein and antibody array techniques”

Fall 2011

Dr. Lesley Davenport - Wednesday, September 21, 2011
Professor and Deputy Chair, Department of Chemistry, Brooklyn College of the
City University of New York, NY
“DNA  Knots and Tumorigenesis: Folding and Conformation of Quadruplex-DNA'’

Dr. Paul Naylor - Wednesday, November 2, 2011
Director Cytokine Biology, IRX Therapeutics, Farmingdale, NY
“IRX-2-A Novel Pleotropic Immune Modulator for Cancer Therapy”

Dr. Simon Geir Møller - Wednesday, November 30, 2011
Professor and EMBO Young Investigator, Department of Biological Sciences, St John's University, NY
“Iron-Sulfur Clusters and Parkinson’s Disease: Using Multiple Models to answer
Complex questions”

Fall 2012

Dr. Niven Narain - Wednesday, October 10, 2012
President & CTO - Berg Biosystems, Natick, MA
“Interrogative biology: A novel platform for the engagement of biointelligence and
drug discovery”

Dr. Renuka Pillutla - Wednesday, November 14, 2012
Associate Director – Bioanalytical  Sciences, Biologics Bristol-Myers Squibb, Princeton, NJ
“Immunogenicity Testing of Biotherapeutics”

Dr. Dana Ferraris - Wednesday, December 5, 2012
Principal Scientist – Brain Science Institute Johns Hopkins University, Baltimore, MD
“Poly (ADP-ribose) Polymerases (PARPs) as therapeutic targets”

Spring 2012

Dr. Prem Premsrirut -Wednesday, February 8, 2012
President and CEO,  Mirimus Inc., Cold Spring Harbor, NY
“RNAi mouse models for target discovery, validation and toxicology assessment'’

Dr. Phil Lukeman -Wednesday, March 14, 2012
Associate Professor of Organic Chemistry, Department of Chemistry, St. John’s University, NY
“Nanochemistry for Noobs: Nanodoodads built by Novices from Nucleic Acids”

Dr. Ray Huang -Wednesday, April 18, 2012
Founder and President , RayBiotech Inc., Norcross, GA
“Accelerated biomedical discovery using protein and antibody array techniques”

Fall 2011

Dr. Lesley Davenport - Wednesday, September 21, 2011
Professor and Deputy Chair, Department of Chemistry, Brooklyn College of the
City University of New York, NY
“DNA  Knots and Tumorigenesis: Folding and Conformation of Quadruplex-DNA'’

Dr. Paul Naylor - Wednesday, November 2, 2011
Director Cytokine Biology, IRX Therapeutics, Farmingdale, NY
“IRX-2-A Novel Pleotropic Immune Modulator for Cancer Therapy”

Dr. Simon Geir Møller - Wednesday, November 30, 2011
Professor and EMBO Young Investigator, Department of Biological Sciences, St John's University, NY
“Iron-Sulfur Clusters and Parkinson’s Disease: Using Multiple Models to answer Complex questions”